Tempus AI stock

TEM · NASDAQ · USD

Compare Tempus AI
$71.60Change from previous close: −5.65%Absolute change: −$4.29

Close · November 13, 2026

Price history

+5.39% over the period

1 year: from $67.94 (November 13, 2025) to $71.60 (November 13, 2026), +5.39%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 13, 2026$71.60
October 30, 2026$72.22
September 30, 2026$81.90
August 31, 2026$63.05
July 31, 2026$43.87
June 30, 2026$57.93
May 29, 2026$50.47
April 30, 2026$55.48
March 31, 2026$45.22
February 27, 2026$53.25
January 30, 2026$59.82
December 31, 2025$59.05
November 28, 2025$77.93
November 13, 2025$67.94

At a glance

  • The company

    Healthcare technology company offering diagnostic testing, clinical applications, and AI-powered analytics for precision medicine

  • Latest results

    Quarter to September 30, 2026 · EPS $0.07 (estimate $0.01)

TickerLandia's take on Tempus AI

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$40.77
52-wk high$89.09

−19.63% from the 52-week high

Analysts · 20 analysts

Average target$89.56+25.08% vs. price

Buy 10 · Hold 10 · Sell 0 · Buy

TickerLandia Fingerprint: Tempus AI

Compared with similar companies: very low earnings stability, very high risk, and very high price.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Tempus AI is pricier than similar companies

Tempus AI's Price/book: 26.0, +297% against the median of a group of 7 similar companies (6.57).

Compared with 7 similar companies

Tempus AI's metrics compared with similar companies
MetricTempus AIPosition in the groupBand
Operating margin-18.5%Middle
ROE-37.6%Low
Debt/equity2.86High
Price/book26.0High
Net margin-12.5%Low

Grey band: the middle half of the group; tick: the median; dot: Tempus AI. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$382.49M

Latest quarter · Q2 2026

Net income

$5.64M

Latest quarter · Q2 2026

Quarterly net margin

1.5%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$13.06B
EPS
-$1.06
Volume
5.31M
Daily trading
€427.94M
Dividend yield
0.00%

How Tempus AI is changing

All results
  • Revenue grew 46.6% a year on average over the last 5 years

  • Operating margin rose from −83.9% to −19.4%

  • Shares outstanding up 177.9% in 5 years

Returns

Tempus AI returns

$1,000 invested in Tempus AI 1 year ago, on November 13, 2025, would be worth $1,054 today: +5.39% in total, +5.39% per year. This is the price return only: dividends are excluded.

PeriodTempus AIS&P 500$1,000 becomes
1 month+4.95%−3.12%$1,050
6 months+55.99%+1.58%$1,560
Year to date+21.25%+10.46%$1,213
1 year+5.39%+12.23%$1,054

Over the last 6 months it has done better than 90% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Tempus AI: technical analysis

Tempus AI shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 30.7% below its all-time closing high ($103.25, October 8, 2025).

Trend
No clear trend
RSI (14 sessions)
47
Between 30 and 70
vs 200-session average
+24.63%

Support and resistance

Price areas where Tempus AI has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$79.37+10.85%2 touches, last on December 8, 2025
  2. Resistance$74.10+3.49%3 touches, last on August 21, 2026
  3. Last price$71.60
  4. Support$62.75−12.36%7 touches, last on November 5, 2026
  5. Support$56.23−21.47%7 touches, last on September 14, 2026
  6. Support$48.59−32.14%7 touches, last on August 18, 2026

Volatility and risk

Over the last year it has moved more than the S&P 500.

Beta (1 year) vs S&P 500
2.44
Volatility (60 sessions, annualised)
88.8%
Largest fall in the last year
−46.68%

Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Tempus AI and its competitors

With revenue of $1.3 billion in the fiscal year ended December 2025, Tempus AI operates its Tempus platform, which links clinician workflows with laboratory diagnostics, analytics and a repository of multimodal data. Its diagnostic offering includes next-generation sequencing tests, large-panel solid tumor and hematologic assays, pharmacogenomic testing for psychiatric conditions and genetic tests for inherited conditions. The group also licenses de-identified clinical, molecular and imaging datasets, offers clinical trial matching and develops software such as Lens, Next and Algos for life sciences research and diagnostics.

Headquarters
Chicago, United States
Employees
3,800
Founded
2015
Chief executive
Eric Lefkofsky
Tempus AI and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Tempus AITEM$13.06B-18.5%—+55.99%
DoximityDOCS$5.95B27.1%46.3+42.54%
Veeva SystemsVEEV$48.82B29.9%49.4+93.62%
Pro MedicusPME$14.57B74.9%81.4+65.15%
M32413$7.61B19.5%26.5+34.35%
XtalPi Holdings2228$3B-124.6%—−32.46%

Same industry or related industries, similar size. Compare Tempus AI with its competitors · Full profile